Japan Market Overview for Interventional Cardiology 2018 - MedView

  • ID: 4482846
  • Report
  • Region: Japan
  • 646 pages
  • iData Research
15 % OFF
until Oct 31st 2018
1 of 4

FEATURED COMPANIES

  • Abbott
  • Biotronik
  • Cardinal Health
  • Medtronic
  • Olympus
  • Stentys
  • MORE
General Report Contents
  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
Japanese hospitals tend to gravitate towards the more expensive and technologically advanced devices; however the high-cost of imaging devices like OCT catheter and FFR guidewires is limiting the market size. Although prices for OCT catheters have decreased over the last several years, these devices are still substantially more expensive when compared to standard diagnostic coronary catheters. In addition to this, IVUS catheters are already so widely accepted in Japan; therefore, prices of OCT catheters will have to decline substantially before penetration rates can reach even half of the IVUS catheter market.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Biotronik
  • Cardinal Health
  • Medtronic
  • Olympus
  • Stentys
  • MORE
EXECUTIVE SUMMARY
JAPAN INTERVENTIONAL CARDIOLOGY MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
PROCEDURES INCLUDED
VERSION HISTORY

1. RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecasts and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE TREATMENTS AND DIAGNOSTICS
2.2.1 General Diagnostics
2.2.2 Coronary Artery Disease (CAD)
2.2.3 Myocardial Infarction (MI)
2.2.4 Angina Pectoris
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Statistics

3. JAPAN INTERVENTIONAL CARDIOLOGY MARKET OVERVIEW
3.1 INTRODUCTION
3.2 CURRENCY EXCHANGE RATE
3.3 MARKET OVERVIEW
3.4 TREND ANALYSIS BY SEGMENT
3.5 DRIVERS AND LIMITERS
3.5.1 Market Drivers
3.5.2 Market Limiters
3.6 COMPETITIVE MARKET SHARE ANALYSIS
3.7 COMPANY PROFILES
3.7.1 Abbott Laboratories
3.7.2 Asahi Intecc
3.7.3 B. Braun
3.7.4 Biosensors
3.7.5 Biotronik
3.7.6 Boston Scientific
3.7.7 Cardinal Health
3.7.8 Cook Medical
3.7.9 Hexacath
3.7.10 Medtronic
3.7.11 Merit Medical Systems
3.7.12 Spectranetics Corporation
3.7.13 Terumo Interventional System (TIS)
3.7.14 Vascular Solutions (Teleflex)
3.7.15 Volcano Corporation (Philips Volcano)
3.8 SWOT ANALYSIS
3.8.1 Abbott Laboratories
3.8.1.1 St. Jude Medical (Abbott Laboratories)
3.8.2 Asahi Intecc
3.8.3 B. Braun
3.8.4 Biosensors
3.8.5 Biotronik
3.8.6 Boston Scientific
3.8.7 Cardinal Health
3.8.7.1 Cordis (Cardinal Health)
3.8.8 Cook Medical
3.8.9 Hexacath
3.8.10 Medtronic
3.8.11 Merit Medical Systems
3.8.12 Spectranetics
3.8.13 Terumo Interventional System (TIS)
3.8.14 Vascular Solutions (Teleflex)
3.8.15 Volcano Corporation (Philips Volcano)

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

List of Charts
Chart 1 1: Interventional Cardiology Market by Segment, Japan, 2014 – 2024
Chart 1 2: Interventional Cardiology Market Overview, Japan, 2017 & 2024
Chart 3 1: Interventional Cardiology Market by Segment, Japan, 2014 – 2024
Chart 3 2: Interventional Cardiology Market Breakdown, Japan, 2017
Chart 3 3: Interventional Cardiology Market Breakdown, Japan, 2024
Chart 3 4: Growth Rates by Segment, Interventional Cardiology Market, Japan, 2014 – 2024
Chart 3 5: Leading Competitors, Interventional Cardiology Market, Japan, 2017

List of Figures:
Figure 1 1: Interventional Cardiology Market Share Ranking by Segment, Japan, 2017 (1 of 2)
Figure 1 2: Interventional Cardiology Market Share Ranking by Segment, Japan, 2017 (2 of 2)
Figure 1 3: Companies Researched in this Report, Japan, 2017
Figure 1 4: Factors Impacting the Interventional Cardiology Market by Segment, Japan (1 of 2)
Figure 1 5: Factors Impacting the Interventional Cardiology Market by Segment, Japan (2 of 2)
Figure 1 6: Recent Events in the Interventional Cardiology Market, Japan, 2014 – 2017
Figure 1 7: Interventional Cardiology Markets Covered, Japan, 2017
Figure 1 8: Interventional Cardiology Procedures Covered, Japan, 2017
Figure 1 9: Version History
Figure 3 1: Currency Exchange Rate, 2017
Figure 3 2: Total Interventional Cardiology Market, Japan, 2014 – 2024 (JP¥M)
Figure 3 3: Total Interventional Cardiology Market, Japan, 2014 – 2024 (US$M)
Figure 3 4: Interventional Cardiology Market by Segment, Japan, 2014 – 2024 (JP¥M) (1 of 2)
Figure 3 5: Interventional Cardiology Market by Segment, Japan, 2014 – 2024 (JP¥M) (2 of 2)
Figure 3 6: Interventional Cardiology Market by Segment, Japan, 2014 – 2024 (US$M) (1 of 2)
Figure 3 7: Interventional Cardiology Market by Segment, Japan, 2014 – 2024 (US$M) (2 of 2)
Figure 3 8: Interventional Cardiology Market Growth by Segment, Japan, 2014 – 2024 (1 of 2)
Figure 3 9: Interventional Cardiology Market Growth by Segment, Japan, 2014 – 2024 (2 of 2)
Figure 3 10: Drivers and Limiters, Interventional Cardiology Market, Japan, 2017
Figure 3 11: Leading Competitors, Interventional Cardiology Market, Japan, 2017 (1 of 2)
Figure 3 12: Leading Competitors, Interventional Cardiology Market, Japan, 2017 (2 of 2)
Figure 3 13: SWOT Analysis, Abbott Laboratories, 2017 (1 of 2)
Figure 3 14: SWOT Analysis, Abbott Laboratories, 2017 (2 of 2)
Figure 3 15: SWOT Analysis, St. Jude Medical, 2017
Figure 3 16: SWOT Analysis, Asahi Intecc, 2017
Figure 3 17: SWOT Analysis, B Braun, 2017
Figure 3 18: SWOT Analysis, Biosensors, 2017
Figure 3 19: SWOT Analysis, Biotronik, 2017
Figure 3 20: SWOT Analysis, Boston Scientific, 2016
Figure 3 21: SWOT Analysis, Cardinal Health, 2017
Figure 3 22: SWOT Analysis, Cordis, 2017
Figure 3 23: SWOT Analysis, Cook Medical, 2016
Figure 3 24: SWOT Analysis, Hexacath, 2017
Figure 3 25: SWOT Analysis, Merit Medical System, 2017
Figure 3 26: SWOT Analysis, Spectranetics, 2017
Figure 3 27: SWOT Analysis, Terumo Interventional System, 2017
Figure 3 28: SWOT Analysis, Vascular Solutions, 2017
Figure 3 29: SWOT Analysis, Volcano Corporation, 2017
Figure 5 1: Press Release Summary
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott
  • Boston Scientific
  • Terumo
  • Medtronic
  • Philips Volcano
  • Goodman Co.
  • Cardinal Health
  • Nipro/InfraReDx
  • Asahi
  • B. Braun
  • Biosensors International Group Ltd.
  • Biotronik
  • C.R. Bard
  • Cardiovascular Systems Inc.
  • Cook Medical
  • Merit Medical
  • Olympus
  • Opsens
  • Stentys
  • Straub Medical
  • Teleflex
  • W. L. Gore
Please Note: Not all companies are currently active in every segment or sub-report from this suite.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll